The board of directors of Simcere Pharmaceutical Group Limited announced that, with effect from May 25, 2022, Mr. Tang Renhong ("Mr. Tang"), an executive Director of the Company, has been appointed as a Co-chief Executive Officer of the Company. Mr. Tang will assist Mr. Ren Jinsheng, Chairman and the Chief Executive Officer of the Company, in the overall leading of the Group's research and development affairs and will remain as an executive Director. Mr. Tang, aged 42, joined the Group in May 2019, and is currently an executive Director and an executive vice president of the Company.

Mr. Tang was primarily responsible for the overall management of Shanghai R&D Center and management of the pre-clinical R&D of innovative pharmaceuticals of the Group. Mr. Tang has nearly 12 years of experience in pharmaceutical research and development and management of pharmaceutical companies.